For: |
Fujino T, Aoyagi Y, Takahashi M, Yada R, Yamamoto N, Ohishi Y, Nishiura A, Kohjima M, Yoshimoto T, Fukuizumi K, Nakashima M, Kato M, Kotoh K, Nakamuta M, Enjoji M. Association of |
---|---|
URL: | https://www.wjgnet.com/2150-5349/full/v4/i3/54.htm |
Number | Citing Articles |
1 |
Daniel Pineda-Tenor, Mónica García-Álvarez, María A. Jiménez-Sousa, Sonia Vázquez-Morón, Salvador Resino. Relationship between ITPA polymorphisms and hemolytic anemia in HCV-infected patients after ribavirin-based therapy: a meta-analysis. Journal of Translational Medicine 2015; 13(1) doi: 10.1186/s12967-015-0682-y
|
2 |
Mohammad Pouryasin, Maryam Keshvari, Heidar Sharafi, Seyed Moayed Alavian, Bita Behnava, Seyed Ehsan Alavian, Ali Pouryasin. The ITPA and C20orf194 Polymorphisms and Hematological Changes During Treatment With Pegylated-Interferon Plus Ribavirin in Patients With Chronic Hepatitis C. Hepatitis Monthly 2016; 16(2) doi: 10.5812/hepatmon.35278
|
3 |
Antonio D'Avolio, Jessica Cusato, Amedeo De Nicolò, Sarah Allegra, Giovanni Di Perri. Pharmacogenetics of Ribavirin-Induced Anemia in Hcv Patients. Pharmacogenomics 2016; 17(8): 925 doi: 10.2217/pgs.16.22
|